# FDA Inspection 1257321 - Chartwell Pharmaceuticals LLC - December 19, 2024

Source: https://www.keypedia.com/records/fda_inspections/chartwell-pharmaceuticals-llc/3e0c11bf-5154-4697-a1d6-e2ef77dec14b
Source feed: FDA_Inspections

> FDA Inspection 1257321 for Chartwell Pharmaceuticals LLC on December 19, 2024. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1257321
- Company Name: Chartwell Pharmaceuticals LLC
- Inspection Date: 2024-12-19
- Project Area: Generic Drug Evaluation
- Product Type: Human Drugs
- Office Name: New York District Office

## Related Documents

- [FDA Inspection 1277530 - 2025-11-18](https://www.keypedia.com/records/fda_inspections/chartwell-pharmaceuticals-llc/11d3e553-14c5-43ff-beb2-f6ce814ef92c)
- [FDA Inspection 1257321 - 2024-12-19](https://www.keypedia.com/records/fda_inspections/chartwell-pharmaceuticals-llc/5e708f24-2e9e-4c56-8797-4d6e0fdc2511)
- [FDA Inspection 1230475 - 2024-04-08](https://www.keypedia.com/records/fda_inspections/chartwell-pharmaceuticals-llc/8d444b79-8c46-47c6-be01-f5119734136c)
- [FDA Inspection 1206056 - 2023-05-24](https://www.keypedia.com/records/fda_inspections/chartwell-pharmaceuticals-llc/477cac0d-4d79-4668-bd49-e0a78e758ada)
- [FDA Inspection 1068395 - 2018-09-26](https://www.keypedia.com/records/fda_inspections/chartwell-pharmaceuticals-llc/ce599aaf-7679-4329-b697-cd159f9d72e3)

Company: https://www.keypedia.com/companies/chartwell-pharmaceuticals-llc/4a8c4844-be98-403a-8cb5-5fc90d592679

Office: https://www.keypedia.com/offices/new-york-district-office/9fa3d265-16ca-438d-8a6e-b47f60dc260d